journal article Jan 01, 2002

Hemodynamic and Plasma Atrial Natriuretic Peptide Responses to Acute Digitalis Therapy in Patients with Normal and Impaired Left Ventricular Function

View at Publisher Save 10.1016/s1388-9842(01)00197-0
Abstract
Abstract

Background
Digitalis has a long history in the treatment of heart failure but its effects on cardiac hemodynamics and neurohormonal modulation are not well characterized.


Aims
The purpose of this study was to evaluate the relationship between atrial natriuretic peptide (ANP) and the hemodynamic responses to acute digitalis administration in patients with normal and impaired left ventricular function (LVD).


Methods and Results
Thirty patients were enrolled in the study, 20 with LVD (LVEF-22±8%) and 10 control subjects (LVEF-77±10%). Hemodynamics and plasma ANP concentrations were measured supine and with leg elevation before and after digitalis. In patients with normal ventricular function, the hemodynamic stress of leg elevation in the pre-digitalis state resulted in significant (P<0.05) increases in PAWP and MPAP. Digitalis administration in the supine position produced reductions in heart rate, PAWP, MPAP and CI; SVR was increased. In LVD patients leg elevation further increased PAWP, RAP and MPAP. Digitalis in the supine position, however, reduced RAP, MPAP and PAWP and increased CI. These improved hemodynamics were preserved during the stress of leg elevation. Leg elevation following digitalis resulted in increased ANP concentrations despite decreased cardiac filling pressures.


Conclusions
Acute digitalis administration results in hemodynamic improvement in LVD patients which may in part result from digitalis stimulated release of myocardial ANP under conditions of hemodynamic stress.
Topics

No keywords indexed for this article. Browse by subject →

References
26
[1]
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
New England Journal of Medicine 1997 10.1056/nejm199702203360801
[2]
Burnett "Atrial natriuretic peptide elevation in congestive heart failure in the human" Science (1986) 10.1126/science.2935937
[3]
Francis "Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD)" Circulation (1990) 10.1161/01.cir.82.5.1724
[4]
Yamamoto "Effects of hypercalcemia and ouabain on plasma atrial natriuretic polypeptide in anesthetized dogs" Am J Physiol (1988)
[5]
London "Hemodynamic effects of head-down tilt in normal subjects and sustained hypertensive patients" Am J Physiol (1983)
[6]
Rodeheffer "Atrial pressure and secretion of atrial natriuretic factor into the human central circulation" J Am Coll Cardiol (1986) 10.1016/s0735-1097(86)80086-9
[7]
Braunwald "Studies on digitalis. IV. Observations in man of the effects of digitalis preparations on the contractility of the nonfailing heart and on vascular resistance" J Clin Invest (1961) 10.1172/jci104236
[8]
DeMots "Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure" Am J Cardiol (1978) 10.1016/0002-9149(78)90137-6
[9]
Newton "Digoxin reduces cardiac sympathetic activity in severe congestive heart failure" J Am Coll Cardiol (1996) 10.1016/0735-1097(96)00120-9
[10]
Ferguson "Sympathoinhibitory responses to digitalis glycosides in heart failure patients" Circulation (1989) 10.1161/01.cir.80.1.65
[11]
Thomes "Sensitization of cardiac receptors (vagal offerens) by intracoronary acethylstrophanihidin" Am J Physiol (1980)
[12]
Thomes "Sensitization of vagal cardiopulmonary baroreflex by chronic digoxin" Am J Physiol (1982)
[13]
Bloomfield "The effects of the cardiac glycosides upon the dynamics of the circulation in congestive heart failure" J Clin Invest (1948) 10.1172/jci102004
[14]
Mason "Studies on digitalis. X. Effects of ouabain on forearm resistance and venous tone in normal subjects and in patients in heart failure" J Clin Invest (1964) 10.1172/jci104939
[15]
Weissler "The effect of deslanoside on the duration of the phases of ventricular systole in man" Am J Cardiol (1965) 10.1016/0002-9149(65)90449-2
[16]
Shapiro "Relationship of plasma digitoxin and digoxin to cardiac response following intravenous digitalization in man" Circulation (1970) 10.1161/01.cir.42.6.1065
[17]
Carliner "Effects on maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations" Circulation (1974) 10.1161/01.cir.50.1.94
[18]
Gheorghiade "Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators" J Am Coll Cardiol (1987) 10.1016/s0735-1097(87)80241-3
[19]
Gheorghiade "Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors" Circulation (1995) 10.1161/01.cir.92.7.1801
[20]
Ware "Effect of digoxin on ejection fraction in elderly patients with congestive heart failure" J Am Geriatr Soc (1984) 10.1111/j.1532-5415.1984.tb02249.x
[21]
Cohn "Variability of hemodynamic responses to acute digitalization in chronic cardiac failure due to cardiomyopathy and coronary artery disease" Am J Cardiol (1975) 10.1016/0002-9149(75)90827-9
[22]
Ribner "Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic hormonal study" Am J Cardiol (1985) 10.1016/0002-9149(85)90778-7
[23]
Slatton "Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm" J Am Coll Cardiol (1997) 10.1016/s0735-1097(97)00057-0
[24]
Bloch "Ouabain induces secretion of proatrial natriuretic factor by rat atrial cardiocytes" Am J Physiol (1988)
[25]
Schiebinger "Ouabain. A stimulator of atrial natriuretic peptide secretion and its mechanism of action" Circ Res (1993) 10.1161/01.res.72.5.1035
[26]
Tsutamoto "Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure" Am Heart J (1997) 10.1016/s0002-8703(97)80014-2